Navigation Links
Talyst Unveils InSite for Long-Term Care

BELLEVUE, Wash., Nov. 19 /PRNewswire/ -- Talyst, a leader in automated medication management, today unveiled InSite(TM) for Long-Term Care. InSite is the first remote dispensing system designed exclusively for long-term care facilities and the patients in their care.

The company made the announcement at the annual meeting of the American Society of Consultant Pharmacists, underway this week in New Orleans. The first installations of the InSite system are operating in Texas, and each InSite unit will deliver an estimated 1.5 million oral medication doses per year. The automated system enables on-site, on-demand medication dispensing for an entire facility. With InSite for Long-Term Care, medication waste is virtually eliminated. The hardware and software solution cuts nursing medication prep time in half and allows late admissions and quick first doses.

The benefits of remote dispensing

InSite allows an institutional pharmacy to place a secure, freestanding remote dispensing system at each long-term care facility they support. "Talyst is continuing to build market leadership through innovation," explains Carla Corkern, chief executive officer, "and InSite is our response to a clear need in the long-term care industry." She added, "With a national nursing shortage, rising medication budgets and the need for improved medication safety, InSite for Long-Term Care can help both facilities and pharmacies save time and reduce waste while creating a safer medication process."

The InSite Remote Dispensing System improves the partnership between pharmacies and the facilities they support. Medication orders are submitted to the institutional pharmacy for clinical review, and approved orders are available immediately from the remote dispensing unit at the facility. Rather than filling medication orders for 30 days at a time, InSite enables medications to be sorted by patient and packaged at the facility. The clearly labeled multi-dose and single-dose packages are prepared on demand with patient name, med pass time and a detailed listing of each medication. Medication usage is monitored at the institutional pharmacy to provide complete inventory control and medication canisters are safely filled and secured for transportation to the facility as needed.

"In early installations of InSite, nursing medication prep time was reduced by about 75%, and the institutional pharmacy was able to reduce the number of trips made to the facility each week, and Medicare Part A waste was nearly eliminated," Corkern noted. "In addition, medications for new patients, or changes to an existing patient's medications, are available to nursing staff virtually immediately."

Corkern concludes, "The bottom line is that InSite reduces costs, saves time and keeps the patients safer."

About Talyst

Talyst enables the safer pharmacy. The company provides automated systems to hospitals, long-term care facilities and correctional systems, to improve accuracy and patient safety, while reducing costs and increasing productivity. Talyst equipment and software are used to package, barcode, store and track medication inventories. The company has more than 300 hospital and integrated healthcare system customers.

For more information, see or call 877-4-Talyst (877-482-5978).

For the last two years, Talyst has ranked in the "Inc. 500" national list of fastest-growing private companies. Last month, the company was ranked number two on the Deloitte "Fast 50" Technology Companies in Washington state. Talyst was also honored by Fast Company magazine's "Fast 50 Reader Favorites" list, honoring innovative, progressive enterprises.

Talyst and InSite are trademarks of Talyst Inc. Other trade names are the property of their respective owners.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
2. Catalyst mystery unlocked
3. CATalyst Council Forms to Address Feline Health Care
4. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
5. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
6. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
7. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
8. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
9. CATalyst Summit Declared a Success: Its All About the Cat!
10. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
11. Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
Post Your Comments:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: